Skip to page content

Seattle's Know Labs bolsters exec team ahead of clinical trials for glucose monitoring device


Steve Kent Headshot.v1
Steven Kent is joining Know Labs from Oura.
Know Labs

Seattle-based medical technology company Know Labs Inc. has named Steven Kent as chief product officer and Peter Conley as chief financial officer and senior vice president of intellectual property.

The new hires come as Know Labs is enrolling patients for clinical trials to test its blood glucose monitoring device. Know Labs' technology uses radio waves to monitor blood glucose levels with the goal of avoiding finger pricks or transmitters.

“Pete and Steve bring tremendous expertise that will help us refine and execute our IP strategy, product innovation and machine learning progress,” CEO Phil Bosua said in a news release. “By strengthening our executive leadership team, we are better positioned to tackle the milestones needed for the (Food and Drug Administration) clearance process.”

Kent was previously the head of health partnerships and corporate strategy at Oura, a company that makes a ring to track metrics like sleep, heart rate and activity. Kent spent almost three years at Oura, according to his LinkedIn page. Before that, he was the founder and CEO at a Santa Clara, California-based company called Invicta Medical, which focused on sleep apnea solutions.

Pete Conley Headshot.v1
Peter Conley is Know Labs' chief financial officer and senior vice president of intellectual property.
Know Labs

Conley, meanwhile, is joining Know Labs from the Irvine, California-based investment bank Boustead Securities, where he was senior managing director and head of intellectual property banking. Before that, he was the co-founder and chief operating officer at the intellectual property development firm ipCreate.

Know Labs, a publicly traded company, is developing both a palm-reading blood glucose device called the KnowU and a wristband called the UBand that allows users to check their blood glucose levels through an app. The products are not yet available for sale or cleared by the FDA.

“It is exciting to witness our organization grow,” James Anderson, Know Labs chief medical officer, said in a news release. “I’ve been through this process several times in my career. As we get closer to FDA submission and clearance, the amount of work increases across multiple disciplines; and this requires expertise in each discipline. Having experienced and highly qualified individuals is critical for our success."


Keep Digging



SpotlightMore

Nancy Xiao (left) and Jim Xiao (right) are swapping roles at Seattle-based Mason.
See More
SPOTLIGHT Awards
See More
Image via Getty
See More
Image via Getty Images
See More

Upcoming Events More

Oct
03
TBJ
Oct
17
TBJ

Want to stay ahead of who & what is next? Sent weekly, the Beat is your definitive look at Seattle’s innovation economy, offering news, analysis & more on the people, companies & ideas driving your region forward. Follow the Beat.

Sign Up